Elderly patient with complex concomitant cardiovascular disease
Paziente anziano con complessa condizione cardiovascolare concomitante
DOI:
https://doi.org/10.19156/abtpn.2018.0051Keywords:
Type 2 diabetes, Cardiovascular risk, EmpagliflozinAbstract
The clinical case we present shows that an inadequate pharmacological treatment of type 2 diabetes does not prevent complications affecting especially the cardiovascular system. Cardiovascular events remain the leading cause of death in people with diabetes. The optimal management of the patient described required a global reassessment and the introduction of new therapies which were adapted according to diabetes progression with its associated complications (Diabetology).
Downloads
Download data is not yet available.